| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 11/23/2005 | EP1282430B1 Lipids for stimulation of immune response |
| 11/23/2005 | EP1280777B1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 11/23/2005 | EP1117767B1 Immunomodulation by genetic modification of dendritic cells and b-cells |
| 11/23/2005 | EP1078007B1 Verotoxin b subunit for immunization |
| 11/23/2005 | EP1039930B1 ADJUVANTED VACCINE COMPRISING AN ANTIGEN FROM STREPTOCOCCUS PNEUMONIAE AND A CpG OLIGONUCLEOTIDE |
| 11/23/2005 | EP0939817B1 High-affinity interleukin-4 muteins |
| 11/23/2005 | EP0792347B1 Methods for producing enhanced antigenic helicobacter sp. and vaccines comprising same |
| 11/23/2005 | EP0781344B1 Novel implant and novel vector for the treatment of acquired diseases |
| 11/23/2005 | EP0778780B1 Capsular polysaccharide immunomodulator |
| 11/23/2005 | EP0770129B1 Zinc finger protein derivatives and methods therefor |
| 11/23/2005 | CN1701121A Improved transfection of eukaryontic cells with linear polynucleotides by electroporation |
| 11/23/2005 | CN1701116A Probiotic bacterium: lactobacillus fermentum |
| 11/23/2005 | CN1701061A New compounds for the inhibition of rotamases and use thereof |
| 11/23/2005 | CN1700934A Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 11/23/2005 | CN1700926A Composition containing beta-glucan and constipation-relieving drug, immunopotentiator and skin moistening agent using the composition |
| 11/23/2005 | CN1700917A Combination comprising n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent |
| 11/23/2005 | CN1700916A Use of HIV-protease inhibitors to block cell migration and/or invasion, tissue inflitration and oedema formation |
| 11/23/2005 | CN1698601A Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl iv, processes for their preparation, and their use |
| 11/23/2005 | CN1228450C Antigenic preparations |
| 11/23/2005 | CN1228449C Ganoderma mycellium antitumour water soluble neteropolysaccharide and its preparation method and use |
| 11/23/2005 | CN1228330C Imidazole derivatives or their salts |
| 11/23/2005 | CN1228088C Cross-breed vaccine carrier and its application |
| 11/23/2005 | CN1228084C Method of using Zot or zonulin to inhibit lymphocyte proliferation in antigen-specific manner |
| 11/23/2005 | CN1228074C Chinese traditional medicine for treating immune hypofunction and disfunction |
| 11/22/2005 | US6967214 Inhibitors of IMPDH enzyme |
| 11/22/2005 | US6967197 Also used in production of tumor necrosis factor alpha |
| 11/22/2005 | US6967097 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of viral diseases |
| 11/22/2005 | US6967089 Delivery system for porcine somatotropin |
| 11/22/2005 | US6967023 solidifying agent consists of a long chain fatty alcohol having at least 15 carbon atoms in its backbone and a fatty acid having at least 18 carbons in its backbone; carrier is semi-solid at rest and liquefies upon application of shear forces |
| 11/17/2005 | WO2005108584A1 Recombinant chemokine-antigen vaccine |
| 11/17/2005 | WO2005108400A1 Pyridoquinazoline derivatives having heterobicyclic substituents |
| 11/17/2005 | WO2005107748A2 Method of tonic treatment with oxyphenbutazone derivatives |
| 11/17/2005 | WO2005107736A1 Cla-enriched milkfat and uses thereof |
| 11/17/2005 | WO2005107496A1 Method of producing fresh mushroom extract, extract and extract-containing material |
| 11/17/2005 | WO2005096692A3 Crystalline forms of mizolastine, production methods thereof and pharmaceutical compositions containing same |
| 11/17/2005 | WO2005065063A3 Use of the mushroom agaricus blazei murill for the production of medicaments suitable for treating infections and allergies |
| 11/17/2005 | WO2004073736A8 Attenuated strains of vibrio cholerae and lyophilised vaccines containing same |
| 11/17/2005 | WO2003068941A3 Modulation of immune response by non-peptide binding stress response polypeptides |
| 11/17/2005 | US20050256315 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 11/17/2005 | US20050256311 Pyrimidine compounds |
| 11/17/2005 | US20050256304 Modified factor VIII |
| 11/17/2005 | US20050256166 Nitrogen-containing compounds |
| 11/17/2005 | US20050256163 Crystalline forms of fexofenadine hydrochloride and processes for their preparation |
| 11/17/2005 | US20050256160 Beta-alanine derivatives and the use thereof |
| 11/17/2005 | US20050256122 Substituted pyridazinones |
| 11/17/2005 | US20050256084 Administering stachyose to treat atopic dermatitis; can be added to medicine, food and beverage |
| 11/17/2005 | US20050256082 Allergen inactivator |
| 11/17/2005 | US20050256066 Fredericamycin derivatives |
| 11/17/2005 | US20050256060 Mono-and disaccharide derivatives |
| 11/17/2005 | US20050256051 Nuclear receptor-mediated introduction of a PNA into cell nuclei |
| 11/17/2005 | US20050255576 PGDS inhibitor; antiallergies, sleep control, antiobesity and brain wound healing; Crystals of a complex of human origin hematopoietic prostaglandin D synthase, glutathione and a substrate analog or an inhibitor |
| 11/17/2005 | US20050255549 IRAK-4: compositions and methods of use |
| 11/17/2005 | US20050255529 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor |
| 11/17/2005 | US20050255454 Administering antigens capable of causing specific immune reaction(s) directed against an infectious agent and/or cells infected with the infectious agent, and decreasing a different specific immune reaction direct towards the infectious agent, infected cells and/or uninfected cells; immunotherapy |
| 11/17/2005 | US20050255124 HCV E1E2 vaccine compositions |
| 11/17/2005 | US20050255101 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease |
| 11/17/2005 | US20050255099 Antigenic fusion protein carrying Galalpha 1,3Gal epitopes |
| 11/17/2005 | DE10392697T5 Herstellung und Standardisierung von immunmodulierenden Peptid-verknüpften Glucanen mit nachweisbarer oraler Resorbierbarkeit aus Coriolus Versicolor Preparation and standardization of immunomodulating peptide-linked glucans with detectable oral absorbability from Coriolus Versicolor |
| 11/17/2005 | CA2566398A1 Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin |
| 11/17/2005 | CA2566393A1 Cla-enriched milkfat and uses thereof |
| 11/17/2005 | CA2566228A1 Method of tonic treatment with oxyphenbutazone derivatives |
| 11/16/2005 | EP1595951A1 Diagnosis and treatment of diseases using peptides which are bound by specific anti-anti-t-cell receptor vbeta antibodies |
| 11/16/2005 | EP1595869A1 Pyrimidine derivatives |
| 11/16/2005 | EP1594899A1 Idiotypic vaccine |
| 11/16/2005 | EP1594897A2 Use of il-6 antagonists in combination with steroids to enhance apoptosis |
| 11/16/2005 | EP1594896A1 Modified soluble t cell receptor |
| 11/16/2005 | EP1594841A1 Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines |
| 11/16/2005 | EP1594542A2 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 11/16/2005 | EP1594541A2 Method and compositions for the treatment of meconium aspiration syndrome |
| 11/16/2005 | EP1594525A1 Regulation of allergen induced gene |
| 11/16/2005 | EP1594524A2 Use of tryptanthrin compounds for immune potentiation |
| 11/16/2005 | EP1594522A1 Pharmaceutical combinations comprising corticoids and immunosuppressants for treating corticoid- and/or calcineurin inhibitors-resistant diseases |
| 11/16/2005 | EP1594497A1 Sulfhydantoins as phosphate isosteres for use as phosphatase inhibitors in the treatment of cancer and autoimmune disorders |
| 11/16/2005 | EP1594487A1 Composition comprising cysteamine for improving immunity of animals |
| 11/16/2005 | EP1594434A2 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 11/16/2005 | EP1594432A2 Short immunomodulatory oligonucleotides |
| 11/16/2005 | EP1492795B1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 11/16/2005 | EP1379516B1 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as ip antagonists |
| 11/16/2005 | EP1363631A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 11/16/2005 | EP1307466B1 Immunological adjuvant compounds |
| 11/16/2005 | EP1222191B1 Benzodiazepin derivatives, the production and use thereof |
| 11/16/2005 | EP1218374B1 Pharmaceutically active sulfonamide derivatives |
| 11/16/2005 | EP1196450B1 Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis |
| 11/16/2005 | EP1114052B1 4-aminopyrrolopyrimidines as kinase inhibitors |
| 11/16/2005 | EP1100515B1 EX VIVO TREATMENT OF ALLOGENEIC AND XENOGENEIC T-CELLS WITH gp39 ANTAGONISTS |
| 11/16/2005 | EP0876395B1 Inhibitors of interleukin-1beta converting enzyme |
| 11/16/2005 | CN1697836A Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid compounds as NMDA-antagonists |
| 11/16/2005 | CN1697830A 嘧啶衍生物 Pyrimidine derivatives |
| 11/16/2005 | CN1697655A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 11/16/2005 | CN1696293A Gene recombined chemotaxis antigen vaccine |
| 11/16/2005 | CN1227361C Method of expressing thymus peptide alpha by yeast and use thereof |
| 11/16/2005 | CN1227265C Antibodies to CCR5 |
| 11/16/2005 | CN1227263C Peptide diagnostic and therapeutic agent for autoimmune diseases |
| 11/16/2005 | CN1227248C Imidazolidine derivatives, their preparation, and their use as antinflamatory agent |
| 11/16/2005 | CN1227035C Conjugates and method for production thereof, and their use for transporting molecules via biological membranes |
| 11/16/2005 | CN1227032C Vaccines with an LTB adjuvant |
| 11/16/2005 | CN1227030C Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 11/16/2005 | CN1226982C Oil-in-water emulsion comprising micronised biologically active agent and appropriate emulsified system |
| 11/15/2005 | US6965027 Crystalline 3-{4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile citrate |
| 11/15/2005 | US6965018 Antibodies directed to B7-related polypeptide, BSL-2 |